Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 55
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 2701 | BRAMBLE ENERGY | 5 | 00% | 0 | 5 | 2023–2025 |
| 2702 | BREVETTI ANGELA S R L | 5 | 00% | 0 | 5 | 2022–2026 |
| 2703 | BRILLIANT OPTRONICS | 5 | 00% | 0 | 5 | 2025–2025 |
| 2704 | BRITISH TELECOMMUNICATIONS PUBLIC | 5 | 120% | 0 | 4 | 2021–2023 |
| 2705 | BROMINE COMPOUNDS | 5 | 00% | 0 | 5 | 2023–2025 |
| 2706 | BUNRI INCORPORATION | 5 | 00% | 0 | 5 | 2022–2024 |
| 2707 | BUSCH PRODUKTIONS | 5 | 00% | 0 | 5 | 2022–2025 |
| 2708 | CA TECHNOLOGY SYSTEMS AS | 5 | 00% | 1 | 4 | 2022–2023 |
| 2709 | CABIN AIR GROUP | 5 | 00% | 0 | 5 | 2024–2026 |
| 2710 | CALICO LIFE SCIENCES | 5 | 240% | 0 | 3 | 2021–2025 |
| 2711 | CANSINO BIOLOGICS | 5 | 00% | 0 | 5 | 2024–2025 |
| 2712 | CAPRI MEDICAL | 5 | 00% | 0 | 5 | 2023–2025 |
| 2713 | CARBONCURE TECHNOLOGIES | 5 | 00% | 0 | 5 | 2022–2025 |
| 2714 | CARDIOMECH AS | 5 | 00% | 0 | 5 | 2024–2025 |
| 2715 | CARNA BIOSCIENCES | 5 | 120% | 1 | 3 | 2022–2026 |
| 2716 | CATERPILLAR GLOBAL MINING EQUIPMENT | 5 | 00% | 0 | 5 | 2022–2024 |
| 2717 | CDGM GLASS | 5 | 00% | 0 | 5 | 2022–2025 |
| 2718 | CDW | 5 | 00% | 0 | 5 | 2024–2025 |
| 2719 | CELLRESEARCH | 5 | 00% | 0 | 5 | 2022–2025 |
| 2720 | CELLULOTECH | 5 | 120% | 0 | 4 | 2022–2025 |
| 2721 | CENTESSA PHARMACEUTICALS UK | 5 | 240% | 0 | 3 | 2022–2024 |
| 2722 | CENTROTHERM INTERNATIONAL | 5 | 00% | 0 | 5 | 2022–2026 |
| 2723 | CERNER INNOVATION | 5 | 00% | 0 | 5 | 2024–2025 |
| 2724 | CHANG CHUN PETROCHEMICAL | 5 | 00% | 0 | 5 | 2023–2024 |
| 2725 | CHANGZHENG ENGINEERING | 5 | 00% | 0 | 5 | 2024–2025 |
| 2726 | CHEMO RESEARCH S L | 5 | 00% | 0 | 5 | 2023–2025 |
| 2727 | CHEMTOR LP | 5 | 120% | 0 | 4 | 2022–2025 |
| 2728 | CHINA PETROLEUM AND CHEMICAL | 5 | 00% | 0 | 5 | 2025–2025 |
| 2729 | CHURCH DWIGHT | 5 | 240% | 2 | 1 | 2022–2025 |
| 2730 | CJ LOGISTICS | 5 | 120% | 1 | 3 | 2022–2025 |
| 2731 | CLARITY PHARMACEUTICALS | 5 | 120% | 1 | 3 | 2022–2025 |
| 2732 | CLOUDSTREAM MEDICAL IMAGING | 5 | 00% | 0 | 5 | 2023–2024 |
| 2733 | CM TECHNOLOGIES | 5 | 00% | 0 | 5 | 2022–2024 |
| 2734 | CMBLU ENERGY | 5 | 00% | 0 | 5 | 2022–2025 |
| 2735 | CNH INDUSTRIAL AMERICA | 5 | 120% | 0 | 4 | 2021–2024 |
| 2736 | CODAGENIX | 5 | 00% | 1 | 4 | 2022–2024 |
| 2737 | CODIAK BIOSCIENCES | 5 | 00% | 0 | 5 | 2022–2022 |
| 2738 | COGNEX | 5 | 00% | 0 | 5 | 2024–2024 |
| 2739 | COMPAGNIE PLASTIC OMNIUM SE | 5 | 120% | 0 | 4 | 2022–2024 |
| 2740 | CONGRUENCE MEDICAL SOLUTIONS | 5 | 00% | 0 | 5 | 2022–2025 |
| 2741 | CONSTANTIA PIRK KG | 5 | 120% | 1 | 3 | 2022–2025 |
| 2742 | COPENHAGEN ATOMICS A S | 5 | 00% | 0 | 5 | 2023–2025 |
| 2743 | CORNEX NEW ENERGY | 5 | 120% | 0 | 4 | 2023–2023 |
| 2744 | CORRADA | 5 | 00% | 0 | 5 | 2022–2025 |
| 2745 | CRM ICBG WUXI | 5 | 00% | 0 | 5 | 2023–2023 |
| 2746 | CRODA | 5 | 120% | 0 | 4 | 2022–2025 |
| 2747 | CROSSFOR | 5 | 00% | 0 | 5 | 2022–2026 |
| 2748 | CRRC NANJING PUZHEN | 5 | 360% | 0 | 2 | 2021–2023 |
| 2749 | CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY SHIJIAZHUANG | 5 | 00% | 0 | 5 | 2024–2026 |
| 2750 | CUMMINS SCANIA HPCR SYSTEM | 5 | 00% | 0 | 5 | 2023–2026 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →